The effects of tadalafil and pentoxifylline on apoptosis and nitric oxide synthase in liver ischemia/reperfusion injury
Open Access
- 2 June 2016
- journal article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 32 (7) , 339-347
Abstract
The aim of this study was to investigate the effects of tadalafil (TDF) and pentoxifylline (PTX) on hepatic apoptosis and the expressions of endothelial and inducible nitric oxide synthases (eNOS and iNOS) after liver ischemia/reperfusion (IR). Forty Wistar albino rats were randomly divided into five groups ( n = 8) as follows: sham group; IR group with ischemia/reperfusion alone; low‐dose and high‐dose TDF groups received 2.5 mg/kg and 10 mg/kg TDF, respectively; and PTX group received 40 mg/kg PTX. Blood was collected for the analysis of serum alanine aminotransferase, aspartate aminotransferase, γ‐glutamyl transferase, uric acid, malondialdehyde (MDA), and total antioxidant capacity (TAC). MDA and TAC also were measured in liver tissue. Histopathological examination was performed to assess the severity of hepatic injury. Apoptosis was evaluated using the apoptosis protease‐activating factor 1 (APAF‐1) antibody; the expressions of eNOS and iNOS were also assessed by immunohistochemistry in all groups. Serum alanine aminotransferase, aspartate aminotransferase, γ‐glutamyl transferase, uric acid, MDA, and TAC, tissue MDA and TAC levels, hepatic injury, and score for extent and for intensity of eNOS, iNOS, and apoptosis protease‐activating factor 1 were significantly different in TDF and PTX groups compared to the IR group. High dose‐TDF and PTX have the best protective effect on IR‐induced liver tissue damage. This study showed that TDF and PTX supplementation may be helpful in preventing free oxygen radical damage, lipid peroxidation, hepatocyte necrosis, and apoptosis in liver IR injury and minimizing liver damage.Keywords
This publication has 40 references indexed in Scilit:
- Intraportal versus Systemic Pentoxifylline Infusion after Normothermic Liver Ischemia: Effects on Regional Blood Flow Redistribution and Hepatic Ischemia-Reperfusion InjuryHPB Surgery, 2013
- The nitric oxide pathway – evidence and mechanisms for protection against liver ischaemia reperfusion injuryLiver International, 2012
- Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver diseaseLipids in Health and Disease, 2011
- The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pupsNeuroscience Letters, 2011
- Liver ischemia/reperfusion injury: Processes in inflammatory networks—A reviewLiver Transplantation, 2010
- Sulindac confers high level ischemic protection to the heart through late preconditioning mechanismsProceedings of the National Academy of Sciences, 2009
- Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in ratsInternational Journal Of Impotence Research, 2007
- Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusionHPB, 2007
- Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat liversJournal of Hepatology, 2006
- Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial HypertensionCirculation, 2003